June 18 @ 08:00 - June 22 @ 17:00 UTC+0
Join our experts at #DIA2017 in Chicago, IL, USA June 18-22, 2017!
The North Building @ McCormick Place, 301 S. King Drive, Chicago, IL 60616
Driving Ideas into Action
DIA 2017 is the largest global interdisciplinary event that brings together key thought leaders and innovators from industry, academia, regulatory and government agencies, health, patient, and philanthropic organizations from around the globe - and across all disciplines involved in the discovery, development, and life cycle management of health care products. The goal of the DIA Annual Meeting is to provide you and your team with a rare opportunity to build on what you already know in the development of new therapies and accelerate efforts to enhance health and well-being. Attend to meet with people from around the world, share your views and knowledge, experience cross-functional content with real-world application from top speakers in the industry, and network with peers to build new relationships across multiple disciplines. Hear from the top thought-leaders on global, interdisciplinary topics about the future of therapeutics, and how they affect you. Engage in conversations on today’s priorities. They will be offered daily at DIA 2017 by Mapi’s best and brightest!
Mapi's Event Role:
Exhibitor ~ Featured Speakers/Presentations
Benoit Arnould, PhD - Senior Director, Patient-centered Outcomes (PCO), Mapi Group
- Session 04-12: No More Swag Items for Retention, So Now What Do We Do? Did You Get Why Patients Accept (or Not) Their Long-Term Treatment? Results from an EU study Via Carenity Social Platform
- Session 07-01: Integrating the Patient's Voice Across the Development Program of Rare Diseases; Developing the PKU-QOL: A Long Journey to Integrate the Patients’ Voice into Phenylketonuria Drug Development Programs
Kelly Franchetti, RN, CCRN, CEN - Vice President, Global Patient Insights & Engagement (PI&E), Mapi Group
- Presentation: The Inclusive Clinical Trial: Involving Diverse Populations in Clinical Trial Design
- Presentation: A Mutually Beneficial Partnership: Engaging Advocacy and Patient Groups to Assist with Clinical Trial Recruitment
- Presentation: Medical Affairs Engaging Patients for Post-Marketing Patient Registry
Valerie Powell, MS - Director, Global Patient Insights & Engagement (PI&E), Mapi Group
- Session: Tuesday, June 20 • 2:00pm - 3:15pm ~ #259: Novel Techniques for Improving Clinical Trial Subject Retention
- Presentation: One Size Does Not Fit All: Retention Methods Custom-Designed for Your Specific Patient Population
- Valerie will share proven techniques and approaches to reduce the number of subjects lost to follow up in a clinical trial and discuss the statistical impact of reducing loss to follow up on the validity of clinical trial results.
- Learning Objectives: Describe approaches and techniques for decreasing the number of subjects lost-to-follow-up to reduce the impact on study validity.
- Session: Wednesday, June 21 • 10:30am - 11:45am ~ #315: How to Engage Patients Within Medical Affairs
- Presentation: Medical Affairs Engaging Patients for Postmarketing Patient Registry
- This session will discuss the role of medical affairs in patient involvement, and best practices for incorporating patient-centric initiatives into the medical affairs unit.
- Learning Objectives: Discuss appropriate methods for medical affairs units to engage patients; Discuss ways to obtain patient insights to inform medical affairs strategies; Discuss case studies that leveraged patient engagement in medical affairs.
Will Maier, PhD, MPH - Chief Scientific Officer, Patient-Centered Services, Mapi
- Hybrid Studies Session: Monday, June 19 • 11:00am - 12:15pm ~ #125: Hybrid Study Designs: An Innovate Approach to Obtaining Valuable Information by Combining Existing Data with New Data Length
- Presentation: Why Choosing a Hybrid Design? Insights from a Study with Duchenne Muscular Dystrophy Patients and Caregivers
- Speakers will share innovative approaches to obtaining valuable information by combining existing data with new data.
- Learning Objectives: Define what constitutes a hybrid study design; Explain why hybrid designs are more cost efficient than traditional study designs; Describe at least one example of a hybrid study design.
Additionally attending Mapi experts include:
- Karen Josey
- Stefania Vasarri
- Celine Marcuccilli
- James Karis
- Stephen Doherty
- Barbara Taylor
Register to attend today: